Multi-Omics Target Discovery after Data Integration: An Umbrella Review of Causal Evidence, Reproducibility, and Translational Readiness
Pharmacophore · 2025 · 16 (5) · 78-87
DOI: 10.51847/wnbjf8t1p5 ↗Kurz gefasst
Umbrella Review in der Zeitschrift Pharmacophore, 2025. Verfasst von Nathan Jones und 3 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Multi-omics integration is increasingly used to prioritize therapeutic targets by combining genomic, transcriptomic, proteomic, metabolomic, and related molecular evidence. Yet the accumulation of data layers does not necessarily produce stronger target claims. Reviews differ substantially in their definitions of integration, evidentiary standards, causal assumptions, validation requirements, and interpretation of translational readiness. This umbrella review evaluates how review-level evidence
Zitieren
APA
Jones, N., Taylor, O., Reid, S., & Clarke, D. (2025). Multi-Omics Target Discovery after Data Integration: An Umbrella Review of Causal Evidence, Reproducibility, and Translational Readiness. Pharmacophore, 16(5), 78-87. https://doi.org/10.51847/wnbjf8t1p5
Vancouver
Jones N, Taylor O, Reid S, Clarke D. Multi-Omics Target Discovery after Data Integration: An Umbrella Review of Causal Evidence, Reproducibility, and Translational Readiness. Pharmacophore. 2025;16(5):78-87. doi:10.51847/wnbjf8t1p5
BibTeX
@article{Jones2025,
author = {Jones, Nathan and Taylor, Olivia and Reid, Samantha and Clarke, David},
title = {Multi-Omics Target Discovery after Data Integration: An Umbrella Review of Causal Evidence, Reproducibility, and Translational Readiness},
journal = {Pharmacophore},
year = {2025},
volume = {16},
number = {5},
pages = {78--87},
doi = {10.51847/wnbjf8t1p5}
}
EUVIMED